BUB1 Gene: Mitotic Checkpoint Kinase and Cancer Implications

Comprehensive guide to BUB1 (BUB1 Mitotic Checkpoint Serine/Threonine Kinase): genomic context, protein function, associated diseases, expression, mutations, and pathways.

Gene Information Card

Symbol BUB1
Full Name BUB1 mitotic checkpoint serine/threonine kinase
Gene Type protein coding
Chromosomal Location 2q14.1
NCBI Gene ID 699 ncbi.nlm.nih.gov/gene/699
Ensembl ID ENSG00000169679
UniProt ID O43683
OMIM ID 602452
HGNC ID 1148
Aliases BUB1A; BUB1L; hBUB1

Description

BUB1 (BUB1 mitotic checkpoint serine/threonine kinase) encodes a serine/threonine kinase that is a core component of the spindle assembly checkpoint (SAC). It is essential for proper chromosome segregation during mitosis. BUB1 localizes to kinetochores and is involved in the recruitment of other SAC proteins, including BUBR1 and MAD2, and in the establishment of kinetochore-microtubule attachments. Mutations and altered expression of BUB1 have been implicated in various cancers, contributing to chromosomal instability and aneuploidy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer Altered BUB1 expression and mutations contribute to chromosomal instability (CIN) and aneuploidy, promoting tumorigenesis. Multiple studies (e.g., Cahill et al., 1998; Shichiri et al., 2002) report BUB1 mutations in colorectal cancer cell lines and tumors.
Breast cancer Overexpression of BUB1 is associated with poor prognosis and may drive tumor progression via SAC dysregulation. Gene expression analyses (e.g., TCGA) show BUB1 upregulation in aggressive breast cancer subtypes.
Lung cancer BUB1 overexpression correlates with tumor grade and metastasis, likely due to enhanced mitotic errors. Immunohistochemistry and transcriptomic studies (e.g., Zhang et al., 2019) demonstrate elevated BUB1 in lung cancer tissues.
Hepatocellular carcinoma BUB1 overexpression promotes cell proliferation and chromosomal instability, contributing to liver cancer progression. Studies (e.g., Liu et al., 2020) report BUB1 as a prognostic marker in HCC.
Gastric cancer BUB1 mutations and altered expression are linked to aneuploidy and poor patient outcomes. Research (e.g., Kim et al., 2013) identifies BUB1 as a potential therapeutic target in gastric cancer.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 25.3 High
Bone marrow 18.7 Medium
Lymph node 15.2 Medium
Spleen 12.8 Medium
Thymus 11.9 Medium
Colon 8.5 Low
Lung 6.2 Low
Liver 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical cancer) 20.5 High expression; used in mitotic studies.
MCF7 (breast cancer) 15.3 Elevated; correlates with proliferation.
A549 (lung cancer) 12.1 Moderate; associated with tumor aggressiveness.
HepG2 (liver cancer) 10.8 Moderate; linked to chromosomal instability.
K562 (leukemia) 18.9 High; reflects rapid proliferation.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1970A>G (p.Asn657Ser) Missense Rare (<0.1%) Potential kinase activity alteration; observed in colorectal cancer.
c.2380C>T (p.Arg794Trp) Missense Rare (<0.1%) May affect protein stability; found in gastric cancer.
c.1168C>T (p.Arg390Ter) Nonsense Very rare Truncating mutation; likely loss-of-function.
c.1500_1501insA (frameshift) Insertion Rare Frameshift leading to premature stop; loss-of-function.
c.2210A>G (p.Gln737Arg) Missense Rare Potential impact on kinase domain; reported in lung cancer.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in BUB1 impair spindle assembly checkpoint signaling, leading to premature anaphase and aneuploidy. These are often truncating or missense mutations in the kinase domain.

Gain of Function (GOF)

Gain-of-function mutations are less common but may increase kinase activity, leading to hyperactivation of the SAC and prolonged mitotic arrest, which can contribute to tumorigenesis.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by interfering with wild-type BUB1 function, disrupting SAC signaling and promoting chromosomal instability.

Gene Ontology (GO)

• protein serine/threonine kinase activity • ATP binding
• kinetochore binding • spindle assembly checkpoint signaling
• mitotic cell cycle • chromosome segregation
• cell division

Pathways

Spindle assembly checkpoint (SAC) pathway
Cell cycle - mitosis
Chromosomal instability (CIN) pathway

Protein Summary

BUB1 is a 1085-amino acid protein with an N-terminal kinetochore localization domain and a C-terminal serine/threonine kinase domain. It functions as a key regulator of the spindle assembly checkpoint, ensuring accurate chromosome segregation. BUB1 phosphorylates multiple substrates, including histone H2A, to recruit other checkpoint proteins. Its activity is essential for mitotic fidelity, and dysregulation is linked to cancer.

Related Products

Product name Cat.No. Species Gene ID
BUB1B-PAK6 Knockout HEK293 Cell Line EDJ-KQ1241 Human 106821730 Details Get a Quote
BUB1B-PAK6 Knockout A-549 Cell Line EDJ-KQ20596 Human 106821730 Details Get a Quote
BUB1B-PAK6 Knockout HCT 116 Cell Line EDJ-KQ20597 Human 106821730 Details Get a Quote
BUB1B-PAK6 Knockout HeLa Cell Line EDJ-KQ20598 Human 106821730 Details Get a Quote
BUB1 Knockout HEK293 Cell Line EDJ-KQ50161 Human 699 Details Get a Quote
BUB1 Knockout HeLa Cell Line EDJ-KQ52739 Human 699 Details Get a Quote
BUB1 Knockout A-549 Cell Line EDJ-KQ61210 Human 699 Details Get a Quote
BUB1 Knockout HCT 116 Cell Line EDJ-KQ69703 Human 699 Details Get a Quote
BUB1B (p.K94=) Point Mutation in HAP1 Cell Line EDC03425 Human 701 Details Get a Quote
BUB1B (p.A388=) Point Mutation in HAP1 Cell Line EDC03426 Human 701 Details Get a Quote
BUB1B (c.179+34A>C )Point Mutation in HAP1 Cell Line EDC03424 Human 701 Details Get a Quote
BUB1B (c.1401+24A>G )Point Mutation in HAP1 Cell Line EDC03427 Human 701 Details Get a Quote
Displaying Records 1 To 12 Of 12 Records
Contact Us
*
*
*
*
How did you hear about us: